Video

Primary Sclerosing Cholangitis: Impeding Bile Duct Flow

Author(s):

Amy Jacob

Palak Trivedi, BSc, MBBS, MRCP, University in Birmingham, England, shared his fascination with the enigma that is primary sclerosing cholangitis.

Palak Trivedi, BSc, MBBS, MRCP, University in Birmingham, England, shared his fascination with the enigma that is primary sclerosing cholangitis (PSC).

Trivedi also discusses his research surrounding autoimmune and hepato-biliary diseases.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Malin Fromme, MD | Credit: RWTH Aachen
Pavel Strnad, MD | Credit: AASLD
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Gideon Hirschfield, FRCP, PhD | Credit: UHN Foundation
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
Country-Level Socioeconomic Status, Healthcare Impact AKI Outcomes in Cirrhosis
Related Content
HCPLive Clinical Quiz
November 27th 2024

Clinical Quiz: Impact of New MASLD Nomenclature on 2023 AASLD NAFLD Guidance

HCPLive Editorial Staff
Kidney Compass default thumbnail with podcast logo and headshots of hosts Brendon Neuen and Shikha Wadhwani.
October 27th 2024

Kidney Compass: Semaglutide for Nondiabetic Kidney Disease, with Hiddo Heerspink, PhD, PharmD, at Kidney Week 2024

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Zahi Touma, MD, PhD, director, Toronto Lupus Program and Associate Professor of medicine, department of medicine, division of rheumatology, Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto
November 27th 2024

Anifrolumab Delayed Onset of Organ Damage in Patients With SLE

Victoria Johnson
Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024
October 27th 2024

Kidney Compass: Atacicept for IgAN with Jonathan Barratt, MD, PhD, at Kidney Week 2024

Brendon Neuen, MBBS, PhD Shikha Wadhwani, MD, MS
Bimekizumab Maintains Efficacy for PsA Up to 2 Years Among Week 16 Responders
November 25th 2024

Bimekizumab Maintains Efficacy for PsA Up to 2 Years Among Week 16 Responders

Tim Smith
Laure Gossec, MD, PhD, Professor of Rheumatology, Pitié-Salpêtrière Hospital and Sorbonne University - Pierre et Marie Curie Campus, Paris, France.
Published: November 23rd 2024 | Updated: November 23rd 2024

Real-World Study Confirms Similar Efficacy of Guselkumab and IL-17i for PsA

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.